US Stock MarketDetailed Quotes
SLN Silence Therapeutics
Watchlist
12.860
+0.180+1.42% Close 11/29 16:00 ET
12.8600.0000.00%
Post 16:00 ET
12.980High12.480Low32.61KVolume
12.720Open12.680Pre Close414.64KTurnover0.22%Turnover RatioLossP/E (TTM)497.30MMarket Cap17.99052wk HighLossP/E (Static)38.67MShares4.54552wk Low19.60P/B191.18MFloat Cap35.000Historical High--Dividend TTM14.87MShs Float4.545Historical Low--Div YieldTTM3.94%Amplitude12.717Avg Price1Lot Size
Silence Therapeutics Key Stats
Quarterly+Annual
YOY

(Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -34.67%58.81M | -2.61%50.22M | 6.02%62.87M | -3.25%71.14M | -3.25%71.14M | 17.72%90.02M | -36.53%51.57M | --59.3M | 96.37%73.54M | 96.37%73.54M |
-Cash and cash equivalents | -34.67%58.81M | -42.36%29.72M | -21.19%46.73M | -25.46%54.82M | -25.46%54.82M | 25.95%90.02M | -27.62%51.57M | --59.3M | 167.90%73.54M | 167.90%73.54M |
-Short-term investments | --0 | --20.5M | --16.14M | --16.33M | --16.33M | ---- | ---- | ---- | --0 | --0 |
Receivables | 33.38%17.47M | 86.64%25.32M | 8.95%12.43M | 104.34%17.34M | 104.34%17.34M | 246.64%13.1M | 108.59%13.57M | --11.41M | -74.68%8.49M | -74.68%8.49M |
-Accounts receivable | 255.38%462K | 324.78%12.32M | -34.23%1.69M | 176.44%915K | 176.44%915K | --130K | 562.33%2.9M | --2.57M | -98.87%331K | -98.87%331K |
-Taxes receivable | 31.16%17.01M | 21.86%13M | 21.53%10.74M | 101.41%16.43M | 101.41%16.43M | 243.20%12.97M | 75.83%10.67M | --8.83M | 93.64%8.16M | 93.64%8.16M |
Prepaid assets | ---- | ---- | ---- | 90.30%8.2M | 90.30%8.2M | ---- | ---- | ---- | 9.37%4.31M | 9.37%4.31M |
Other current assets | 9.48%11.32M | -18.58%6.77M | 35.11%8.39M | ---- | ---- | 258.88%10.34M | 130.77%8.32M | --6.21M | ---- | ---- |
Total current assets | -22.79%87.6M | 12.07%82.31M | 8.80%83.68M | 11.99%96.69M | 11.99%96.69M | 36.48%113.46M | -19.59%73.45M | --76.91M | 13.00%86.33M | 13.00%86.33M |
Non current assets | ||||||||||
Net PPE | -16.90%1.93M | 10.10%2.04M | 10.70%2.1M | 13.22%2.2M | 13.22%2.2M | 51.07%2.32M | 41.51%1.85M | --1.9M | 72.49%1.94M | 72.49%1.94M |
-Gross PPE | ---- | ---- | ---- | 0.49%5.48M | 0.49%5.48M | ---- | ---- | ---- | 20.68%5.46M | 20.68%5.46M |
-Accumulated depreciation | ---- | ---- | ---- | 6.55%-3.28M | 6.55%-3.28M | ---- | ---- | ---- | -3.48%-3.51M | -3.48%-3.51M |
Goodwill and other intangible assets | 1.88%8.13M | 3.51%8.08M | 7.76%8.27M | 9.36%8.33M | 9.36%8.33M | 2.43%7.98M | 0.40%7.8M | --7.68M | -6.46%7.62M | -6.46%7.62M |
-Goodwill | -1.55%7.84M | -0.09%7.77M | 4.04%7.96M | 5.49%8.01M | 5.49%8.01M | 2.21%7.96M | 0.22%7.78M | --7.65M | -6.56%7.59M | -6.56%7.59M |
-Other intangible assets | 1,365.00%293K | 1,338.10%302K | 1,247.83%310K | 1,233.33%320K | 1,233.33%320K | 566.67%20K | 200.00%21K | --23K | 41.18%24K | 41.18%24K |
Investments and advances | 0.00%284K | -6.27%284K | -5.65%284K | -5.65%284K | -5.65%284K | -5.96%284K | 0.66%303K | --301K | -0.66%301K | -0.66%301K |
Total non current assets | -2.29%10.34M | 4.44%10.4M | 7.92%10.66M | 9.66%10.81M | 9.66%10.81M | 9.92%10.58M | 6.14%9.96M | --9.88M | 3.02%9.86M | 3.02%9.86M |
Total assets | -21.04%97.94M | 11.16%92.71M | 8.70%94.34M | 11.75%107.5M | 11.75%107.5M | 33.73%124.04M | -17.20%83.4M | --86.78M | 11.89%96.19M | 11.89%96.19M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -19.35%11.95M | 4.25%12.2M | 72.38%13.25M | 163.66%12.04M | 163.66%12.04M | 60.35%14.81M | 48.70%11.7M | --7.68M | 34.67%4.57M | 34.67%4.57M |
-accounts payable | -19.35%11.95M | 4.25%12.2M | 72.38%13.25M | -21.62%3.19M | -21.62%3.19M | 60.35%14.81M | 48.70%11.7M | --7.68M | 77.90%4.07M | 77.90%4.07M |
-Total tax payable | ---- | ---- | ---- | 1,661.03%8.86M | 1,661.03%8.86M | ---- | ---- | ---- | -54.56%503K | -54.56%503K |
Current accrued expenses | ---- | ---- | ---- | -90.52%589K | -90.52%589K | ---- | ---- | ---- | 29.48%6.22M | 29.48%6.22M |
Current debt and capital lease obligation | -59.72%201K | 280.77%198K | 100.00%180K | 225.55%446K | 225.55%446K | 280.92%499K | -70.95%52K | --90K | -59.82%137K | -59.82%137K |
-Current capital lease obligation | -59.72%201K | 280.77%198K | 100.00%180K | 225.55%446K | 225.55%446K | 280.92%499K | -70.95%52K | --90K | -59.82%137K | -59.82%137K |
Current deferred liabilities | -44.74%5.87M | -8.25%7.16M | -45.45%4.34M | 108.71%8.86M | 108.71%8.86M | 17.65%10.62M | 16.21%7.81M | --7.95M | -75.08%4.25M | -75.08%4.25M |
Current liabilities | -30.52%18.02M | -0.01%19.56M | 12.95%17.76M | 44.68%21.94M | 44.68%21.94M | 40.96%25.93M | 32.47%19.56M | --15.73M | -40.70%15.17M | -40.70%15.17M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | --114K | --166K | --218K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Long term capital lease obligation | --114K | --166K | --218K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non current deferred liabilities | -6.50%59.81M | -11.45%60.73M | -10.89%59.77M | -12.44%63.49M | -12.44%63.49M | 10.30%63.97M | 10.10%68.59M | --67.07M | 41.23%72.5M | 41.23%72.5M |
Total non current liabilities | -6.32%59.93M | -11.21%60.9M | -10.56%59.98M | -12.44%63.49M | -12.44%63.49M | 10.30%63.97M | 10.10%68.59M | --67.07M | 41.23%72.5M | 41.23%72.5M |
Total liabilities | -13.31%77.94M | -8.72%80.46M | -6.10%77.75M | -2.56%85.43M | -2.56%85.43M | 17.69%89.91M | 14.39%88.14M | --82.79M | 13.98%87.67M | 13.98%87.67M |
Shareholders'equity | ||||||||||
Share capital | 7.73%5.8M | 22.73%5.51M | 20.36%5.4M | 20.07%5.39M | 20.07%5.39M | 19.94%5.38M | 0.09%4.49M | --4.49M | 7.78%4.49M | 7.78%4.49M |
-common stock | 7.73%5.8M | 22.73%5.51M | 20.36%5.4M | 20.07%5.39M | 20.07%5.39M | 19.94%5.38M | 0.09%4.49M | --4.49M | 7.78%4.49M | 7.78%4.49M |
Retained earnings | -16.41%-290.61M | -16.58%-282.76M | -18.11%-272.41M | -18.07%-263.26M | -18.07%-263.26M | -16.90%-249.64M | -19.09%-242.56M | ---230.65M | -21.04%-222.97M | -21.04%-222.97M |
Paid-in capital | 6.50%246.82M | 23.98%235.03M | 22.37%231.92M | 22.34%231.86M | 22.34%231.86M | 22.28%231.75M | 0.03%189.56M | --189.53M | 19.25%189.53M | 19.25%189.53M |
Gains losses not affecting retained earnings | -1.12%24.2M | 0.72%24.14M | 1.79%24.29M | 2.29%24.33M | 2.29%24.33M | 1.85%24.48M | -0.18%23.97M | --23.87M | -2.77%23.79M | -2.77%23.79M |
Other equity interest | 52.39%33.78M | 53.27%30.34M | 63.46%27.39M | 73.50%23.75M | 73.50%23.75M | 86.84%22.17M | 111.88%19.79M | --16.75M | 139.51%13.69M | 139.51%13.69M |
Total stockholders'equity | -41.41%20M | 358.57%12.26M | 315.79%16.59M | 158.88%22.07M | 158.88%22.07M | 108.62%34.13M | -120.03%-4.74M | --3.99M | -5.88%8.53M | -5.88%8.53M |
Total equity | -41.41%20M | 358.57%12.26M | 315.79%16.59M | 158.88%22.07M | 158.88%22.07M | 108.62%34.13M | -120.03%-4.74M | --3.99M | -5.88%8.53M | -5.88%8.53M |
Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--